Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance

Clinical trial NCT00241072 · COMPLETED

Trial details

NCT number: NCT00241072
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Impaired Glucose Tolerance

Start date: 2002-09-01
Primary completion: 2005-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.